THE CALANDRA REPORT: Subscribe $91 yearly SAN DIEGO — Inovio Pharmaceuticals (INO in USA), a DNA vaccine developer I sidestepped for four years, is having success with a Middle Eastern virus. INO shares are raging today. Inovio’s J, Joseph Kim, via a persistent biz-dev executive, Bernie Hertel, has been on me, professionally, since 2009. Inovio… Continue Reading
The Dig - Haywood Mining Team's week in review
Contrarian Giustra Likes Mining Developers
Bad News for Gold Bulls
Toronto Investors: 8 Reasons to Attend #Canvest14
Double-Bottom for Gold?
Pain In Portugal: Colt’s Rocky Path